English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  51935620    ???header.onlineuser??? :  872
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"liau j y"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 36-60 of 260  (11 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-09-04T03:10:20Z TERT promoter mutations in periocular carcinomas: Implications of ultraviolet light in pathogenesis Lin S.-Y.; SHU-LANG LIAO; Hong J.-B.; Chu C.-Y.; Sheen Y.-S.; Jhuang J.-Y.; Tsai J.-H.; Liau J.-Y.
臺大學術典藏 2021-09-01T01:54:21Z Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia Lin C.-H.; Liau J.-Y.; Lu Y.-S.; Huang C.-S.; Lee W.-C.; Kuo K.-T.; Shen Y.-C.; Kuo S.-H.; Lan C.; Liu J.M.; Kuo W.-H.; Chang K.-J.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:16Z Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin Shao Y.-Y.; Kuo K.-T.; Hu F.-C.; Lu Y.-S.; Huang C.-S.; Liau J.-Y.; Lee W.-C.; Hsu C.; Kuo W.-H.; Chang K.-J.; Lin C.-H.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:53:55Z KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Ou D.-L.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:53:54Z Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; ANN-LII CHENG
臺大學術典藏 2021-08-31T06:42:23Z Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; ANN-LII CHENG
臺大學術典藏 2021-08-31T06:29:50Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; ANN-LII CHENG; Yeh K.-H.
臺大學術典藏 2021-08-31T06:29:44Z BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; ANN-LII CHENG
臺大學術典藏 2021-08-31T06:29:24Z CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer Chen K.-H.; Lin L.-I.; Tseng L.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; ANN-LII CHENG; Yeh K.-H.
臺大學術典藏 2021-08-25T07:45:32Z Expansile kaposiform hemangioendothelioma deformed thoracic cage in an adult Wu C.-H.; TUNG-MING TSAI; Liau J.-Y.; Chang Y.-L.; Lai H.-S.; Lee J.-M.
臺大學術典藏 2021-08-20T08:00:41Z Computed tomographic characteristics for patients with unresectable gastric cancer harboring low-volume peritoneal carcinomatosis Guo J.-C.; Chang C.-C.; Yang C.-Y.; BIN-CHI LIAO; Liau J.-Y.; Chang C.-H.; Yeh K.-H.
臺大學術典藏 2021-08-20T06:57:46Z Lymphadenopathy Associated with Neutralizing Anti-interferon-gamma Autoantibodies Could Have Monoclonal T-cell Proliferation Indistinguishable from Malignant Lymphoma and Treatable by Antibiotics: A Clinicopathologic Study Yuan C.-T.; JANN-TAY WANG; Sheng W.-H.; Cheng P.-Y.; Kao C.-J.; Wang J.-Y.; Chen C.-Y.; Liau J.-Y.; Tsai J.-H.; Lin Y.-J.; Chen C.-C.; Chen Y.-C.; Chang S.-C.; Wu U.-I.
臺大學術典藏 2021-08-20T04:24:46Z Lymphadenopathy Associated with Neutralizing Anti-interferon-gamma Autoantibodies Could Have Monoclonal T-cell Proliferation Indistinguishable from Malignant Lymphoma and Treatable by Antibiotics: A Clinicopathologic Study Yuan C.-T.; Wang J.-T.; Sheng W.-H.; Cheng P.-Y.; Kao C.-J.; Wang J.-Y.; Chen C.-Y.; Liau J.-Y.; Tsai J.-H.; Lin Y.-J.; Chen C.-C.; Chen Y.-C.; SHAN-CHWEN CHANG; Wu U.-I.
臺大學術典藏 2021-08-20T02:45:42Z BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer KUO-HSING CHEN; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2021-08-20T02:45:41Z An Integrative Morphomolecular Classification System of Gastric Carcinoma with Distinct Clinical Outcomes Tsai J.-H.; Jeng Y.-M.; KUO-HSING CHEN; Lee C.-H.; Yuan C.-T.; Liau J.-Y.
臺大學術典藏 2021-08-20T02:45:41Z CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer KUO-HSING CHEN; Lin L.-I.; Tseng L.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2021-08-18T07:39:07Z Computed tomographic characteristics for patients with unresectable gastric cancer harboring low-volume peritoneal carcinomatosis JHE-CYUAN GUO; Chang C.-C.; Yang C.-Y.; Liao B.-C.; Liau J.-Y.; Chang C.-H.; Yeh K.-H.
臺大學術典藏 2021-07-28T06:46:57Z Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia CHING-HUNG LIN; Liau J.-Y.; Lu Y.-S.; Huang C.-S.; Lee W.-C.; Kuo K.-T.; Shen Y.-C.; Kuo S.-H.; Lan C.; Liu J.M.; Kuo W.-H.; Chang K.-J.; Cheng A.-L.
臺大學術典藏 2021-05-07T02:46:38Z Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients Lin Y.-.; YI-HSIN LIANG; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2021-05-07T02:46:37Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations YI-HSIN LIANG; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2021-05-03T02:21:01Z Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; JIN-TUNG LIANG; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2021-05-03T02:20:57Z Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; JIN-TUNG LIANG; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2021-05-03T02:20:55Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Jin-Tung Liang;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Chang Y.-L.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; JIN-TUNG LIANG; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2021-05-03T02:20:53Z BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; JIN-TUNG LIANG; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2021-05-03T02:20:44Z CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer Chen K.-H.;Lin L.-I.;Tseng L.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Jin-Tung Liang;Lin B.-R.;Cheng A.-L.;Yeh K.-H.; Chen K.-H.; Lin L.-I.; Tseng L.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; JIN-TUNG LIANG; Lin B.-R.; Cheng A.-L.; Yeh K.-H.

顯示項目 36-60 / 260 (共11頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目